Clinical Trials Logo

Clinical Trial Summary

Fetal inflammatory response syndrome (FIRS) is a major cause of non-hypoxic fetal intrapartum injury. One of the most common determinants of FIRS during labor is the exposure to an ongoing intra-amniotic infectious agent as in the event of a chorioamnionitis. Interleuchine-6 (IL-6) is considered a reliable hallmark of FIRS. No specific fetal heart rate pattern for the diagnosis of FIRS have been described so far at intrapartum Cardiotocography (CTG). The aim the present study is to investigate the correlation between intrapartum CTG findings and IL-6 levels on the arterial cord.


Clinical Trial Description

The labor will be managed according to the local protocol and 5mL of blood will collected from the umbilical artery soon after birth to determine the IL-6 values. CardioTocography (CTG) traces will be retrospectively reviewed by two expert operators that will be blinded to the IL-6 results and will categorize them as "inflammatory" or "not inflammatory". Inflammatory pattern will be defined in presence of 1) inappropriately high FHR for the given gestational age and/or 2) an increase >10% compared with the FHR baseline values at admission without preceding deceleration with/without reduced variability or absent cycling. The association between CTG findings as the umbilical levels of IL6 will be analyzed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05793970
Study type Observational
Source Parma University Hospital
Contact Tullio Ghi, Professor
Phone +390521702434
Email tullio.ghi@unipr.it
Status Recruiting
Phase
Start date March 25, 2022
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT06099938 - Effect of Different Labour Analgesics on Maternal and Fetal Blood Flow Observed by Doppler Ultrasonography
Completed NCT04155944 - Diagnosis of Prader-Willi Syndrome and Angelman Syndrome
Recruiting NCT04563065 - Active Pregnancy Against COVID-19 N/A